Efficacy and Safety of Talazoparib Versus Physician's Choice of Chemotherapy in US Patients with HER2-negative Germline BRCA1/2-Mutated (gBRCAm) Locally Advanced/Metastatic Breast Cancer (EMBRACA)

Reshma Mahtani

Research output: Contribution to conference › Presentation

Abstract

S. Diab; H.S. Rugo; L.A. Mina; S. Puhalla; N.L. Henry; N. Denduluri; D. Yardley; Y. Wang; L. Shahied Arruda; I.C. Tudor; E. Gauthier. A, Czibere; J.K. Litton; S. Hurvitz
Original languageAmerican English
StatePublished - 2020
EventMetastatic Breast Cancer Conference -
Duration: Jan 1 2020 → …

Conference

ConferenceMetastatic Breast Cancer Conference
Period1/1/20 → …

Disciplines

  • Medicine and Health Sciences

Cite this